SOPHiA GENETICS SA (SOPH) Balance Sheet
SOPH balance sheet, 2025
December 31, 2025 · U.S. dollars$163.5M assets = $116.3M liabilities + $47.1M equity
Both columns are drawn to the same scale: what SOPH owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SOPH financial health
Descriptive bands, not a rating. Fiscal 2025.
SOPH balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $76.6M2018 | $163.5M2025 | +11.4%/yr | |
| Total liabilities | $21.8M2018 | $116.3M2025 | +27.0%/yr | |
| Shareholders’ equity | $54.8M2018 | $47.1M2025 | −2.1%/yr | |
| Cash & short-term investments | $54.3M2018 | $70.3M2025 | +3.8%/yr | |
| Total debt | $9.2M2018 | $63.0M2025 | +31.6%/yr | |
| Net cash (debt) | $45.1M2018 | $7.3M2025 | −$37.8M | |
| Working capital | $51.3M2018 | $48.6M2025 | −$2.8M | |
| Book value per share | $0.872018 | $0.702025 | −3.0%/yr | |
| Current ratio | 5.502018 | 1.962025 | −3.54 | |
| Debt / equity | 0.172018 | 1.342025 | +1.17 | |
| Shares outstanding | 63.3M2018 | 67.5M2025 | +0.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SOPH assets
SOPH liabilities and equity
SOPH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SOPH balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $70.3M | $80.2M | $123.3M | $178.6M | $265.3M | $97.3M | $18.4M | $54.3M |
| Cash & equivalents | $70.3M | $80.2M | $123.3M | $161.3M | $193.0M | $74.6M | $18.1M | $53.9M |
| Short-term investments | — | — | $0 | $17.3M | $72.4M | $22.7M | $366,000 | $413,000 |
| Receivables | $18.5M | $8.7M | $15.2M | $8.1M | $7.1M | $7.9M | $9.7M | $5.1M |
| Inventory | $6.4M | $5.9M | $6.5M | $5.2M | $5.7M | $3.4M | $3.6M | $2.9M |
| Other current assets | $3.9M | $4.6M | $3.1M | $4.4M | $4.7M | $1.1M | $2.0M | $421,000 |
| Total current assets | $99.1M | $99.4M | $148.0M | $196.3M | $282.9M | $109.7M | $33.8M | $62.7M |
| Property, plant & equipment (net) | $18.0M | $19.4M | $23.1M | $21.4M | $16.0M | $5.5M | $6.4M | $4.5M |
| Goodwill & intangible assets | $35.9M | $29.0M | $27.2M | $20.0M | $15.7M | $13.3M | $10.2M | $8.5M |
| Long-term investments | $2.0M | $0 | $0 | $0 | $0 | $775,000 | $373,000 | $260,000 |
| Other non-current assets | $8.5M | $7.5M | $7.8M | $6.2M | $5.7M | $2.8M | $839,000 | $616,000 |
| Total assets | $163.5M | $155.3M | $206.2M | $243.8M | $320.2M | $132.1M | $51.7M | $76.6M |
| Liabilities | ||||||||
| Accounts payable | $5.3M | $1.9M | $2.3M | $2.2M | $2.3M | $1.3M | $1.7M | $851,000 |
| Short-term debt | $2.7M | $2.2M | $2.9M | $2.7M | $1.8M | $3.9M | $3.2M | $2.5M |
| Deferred revenue | $16.7M | $5.7M | $9.5M | $3.4M | $4.1M | $2.6M | $2.1M | $1.9M |
| Total current liabilities | $50.5M | $26.8M | $35.6M | $26.8M | $28.6M | $21.6M | $19.3M | $11.4M |
| Long-term debt | $47.7M | $13.2M | $0 | $0 | $0 | $457,000 | $1.6M | $3.9M |
| Lease obligations | $15.3M | $16.8M | $18.6M | $16.7M | $13.1M | $3.9M | $4.6M | $3.4M |
| Other long-term liabilities | $18.0M | $18.8M | $19.1M | $16.9M | $16.2M | $9.6M | $8.5M | $6.5M |
| Total liabilities | $116.3M | $58.8M | $54.7M | $43.7M | $44.8M | $31.6M | $29.4M | $21.8M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $4.8M | $4.2M | $4.0M | $3.5M | $3.3M | $2.5M | $1.9M | $1.9M |
| Retained earnings (deficit) | −$519.3M | −$440.3M | −$377.8M | −$298.8M | −$211.4M | −$137.7M | −$98.3M | −$64.5M |
| Accumulated other comprehensive income | $89.2M | $61.0M | $54.0M | $24.0M | $12.5M | $8.3M | −$581,000 | −$47,000 |
| Total shareholders' equity | $47.1M | $96.5M | $151.4M | $200.1M | $275.4M | $100.5M | $22.3M | $54.8M |
| Key figures | ||||||||
| Total debt | $63.0M | $30.0M | $18.6M | $16.7M | $13.1M | $7.2M | $8.5M | $9.2M |
| Net cash (debt) | $7.3M | $50.2M | $104.7M | $161.9M | $252.3M | $90.1M | $10.0M | $45.1M |
| Working capital | $48.6M | $72.6M | $112.4M | $169.4M | $254.3M | $88.1M | $14.5M | $51.3M |
| Tangible book value | $11.3M | $67.5M | $124.3M | $180.2M | $259.7M | $87.2M | $12.0M | $46.3M |
| Book value per share | $0.70 | $1.47 | $2.34 | $3.12 | $4.98 | $2.09 | $0.35 | $0.87 |
| Shares outstanding | 67.5M | 65.8M | 64.8M | 64.1M | 55.3M | 48.0M | 63.9M | 63.3M |
| Current ratio | 1.96 | 3.71 | 4.16 | 7.32 | 9.89 | 5.08 | 1.75 | 5.50 |
| Quick ratio | 1.76 | 3.32 | 3.89 | 6.96 | 9.52 | 4.87 | 1.46 | 5.21 |
| Debt / equity | 1.34 | 0.31 | 0.12 | 0.08 | 0.05 | 0.07 | 0.38 | 0.17 |
| Equity / assets | 28.8% | 62.1% | 73.5% | 82.1% | 86.0% | 76.1% | 43.1% | 71.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $107.7M | $65.4M | $70.3M | $81.6M | $94.8M | $68.5M | $80.2M | $95.8M | $105.4M | $103.7M | $123.3M | $132.8M |
| Cash & equivalents | $107.7M | $65.4M | $70.3M | $81.6M | $94.8M | $68.5M | $80.2M | $95.8M | $105.4M | $103.7M | $123.3M | $132.8M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $14.1M | $14.3M | $16.5M | $8.5M | $9.5M | $10.7M | $8.7M | $9.8M | $9.9M | $10.9M | $15.2M | $9.8M |
| Inventory | $7.1M | $7.1M | $6.4M | $6.7M | $6.2M | $5.0M | $5.9M | $6.5M | $6.5M | $6.0M | $6.5M | $5.2M |
| Other current assets | $8.4M | $9.0M | $5.9M | $6.7M | $6.5M | $5.8M | $4.6M | $5.2M | $3.9M | $4.5M | $3.1M | $5.3M |
| Total current assets | $137.3M | $95.8M | $99.1M | $103.5M | $117.0M | $90.1M | $99.4M | $117.2M | $125.8M | $125.1M | $148.0M | $153.1M |
| Property, plant & equipment (net) | $15.9M | $16.8M | $18.0M | $17.6M | $18.5M | $19.0M | $19.4M | $21.8M | $20.2M | $21.3M | $23.1M | $22.1M |
| Goodwill & intangible assets | $36.2M | $35.8M | $35.9M | $34.7M | $67.5M | $60.0M | $29.0M | $30.4M | $27.4M | $26.3M | $27.2M | $23.5M |
| Long-term investments | $0 | $0 | $2.0M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $9.0M | $8.6M | $8.0M | $7.7M | $0 | $0 | $7.5M | $8.3M | $7.7M | $7.5M | $7.8M | $7.1M |
| Total assets | $198.4M | $157.0M | $163.0M | $163.5M | $177.6M | $146.7M | $155.3M | $177.6M | $181.1M | $180.3M | $206.2M | $205.9M |
| Liabilities | ||||||||||||
| Accounts payable | $11.9M | $12.7M | $5.3M | $6.1M | $7.7M | $4.6M | $1.9M | $5.9M | $5.3M | $6.2M | $2.3M | $6.0M |
| Short-term debt | $2.7M | $2.7M | $2.7M | $2.6M | $2.5M | $2.3M | $2.2M | $2.5M | $2.6M | $2.7M | $2.9M | $2.9M |
| Deferred revenue | $15.6M | $15.9M | $16.7M | $10.0M | $9.6M | $9.8M | $5.7M | $8.2M | $7.9M | $8.3M | $9.5M | $7.1M |
| Total current liabilities | $51.1M | $46.6M | $50.5M | $36.9M | $34.5M | $28.9M | $26.8M | $30.9M | $28.6M | $30.2M | $35.6M | $28.9M |
| Long-term debt | $48.0M | $47.8M | $47.7M | $47.6M | $47.5M | $13.3M | $13.2M | $13.2M | $13.3M | $0 | $0 | $0 |
| Lease obligations | $13.8M | $14.6M | $15.3M | $15.8M | $16.3M | $16.8M | $16.8M | $18.5M | $16.7M | $17.4M | $18.6M | $17.9M |
| Other long-term liabilities | $16.2M | $16.9M | $17.6M | $18.3M | $19.0M | $18.8M | $18.8M | $20.1M | $17.7M | $17.8M | $19.1M | $18.5M |
| Total liabilities | $115.2M | $111.3M | $115.9M | $102.8M | $100.9M | $61.1M | $58.8M | $64.1M | $59.7M | $48.0M | $54.7M | $47.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $4.8M | $4.8M | $4.8M | $4.2M | $4.2M | $4.2M | $4.2M | $4.2M | $4.0M | $4.0M | $4.0M | $4.0M |
| Retained earnings (deficit) | −$561.0M | −$538.6M | −$519.3M | −$500.1M | −$480.1M | −$457.7M | −$440.3M | −$425.1M | −$406.7M | −$391.5M | −$377.8M | −$353.7M |
| Accumulated other comprehensive income | $96.8M | $92.1M | $89.2M | $84.8M | $80.9M | $67.5M | $61.0M | $62.9M | $52.5M | $48.3M | $54.0M | $36.9M |
| Total shareholders' equity | $83.1M | $45.7M | $47.1M | $60.7M | $76.7M | $85.6M | $96.5M | $113.5M | $121.4M | $132.2M | $151.4M | $158.4M |
| Key figures | ||||||||||||
| Total debt | $61.8M | $62.4M | $63.0M | $63.4M | $63.8M | $30.1M | $30.0M | $31.7M | $30.1M | $17.4M | $18.6M | $17.9M |
| Net cash (debt) | $45.8M | $3.0M | $7.3M | $18.2M | $31.0M | $38.4M | $50.2M | $64.1M | $75.3M | $86.3M | $104.7M | $114.9M |
| Working capital | $86.2M | $49.2M | $48.6M | $66.6M | $82.5M | $61.1M | $72.6M | $86.3M | $97.1M | $94.9M | $112.4M | $124.2M |
| Tangible book value | $47.0M | $9.9M | $11.3M | $26.0M | $9.2M | $25.6M | $67.5M | $83.2M | $94.0M | $105.9M | $124.3M | $134.9M |
| Book value per share | $1.13 | $0.64 | $0.69 | $0.90 | $1.14 | $1.28 | $1.46 | $1.71 | $1.84 | $2.02 | $2.33 | $2.43 |
| Shares outstanding | 73.8M | 71.1M | 68.2M | 67.8M | 67.3M | 66.8M | 65.9M | 66.4M | 65.9M | 65.3M | 65.0M | 65.1M |
| Current ratio | 2.69 | 2.06 | 1.96 | 2.80 | 3.39 | 3.11 | 3.71 | 3.80 | 4.40 | 4.14 | 4.16 | 5.30 |
| Quick ratio | 2.38 | 1.71 | 1.72 | 2.44 | 3.03 | 2.74 | 3.32 | 3.42 | 4.03 | 3.80 | 3.89 | 4.94 |
| Debt / equity | 0.74 | 1.37 | 1.34 | 1.04 | 0.83 | 0.35 | 0.31 | 0.28 | 0.25 | 0.13 | 0.12 | 0.11 |
| Equity / assets | 41.9% | 29.1% | 28.9% | 37.1% | 43.2% | 58.4% | 62.1% | 63.9% | 67.1% | 73.4% | 73.5% | 77.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 3, 2026); data from EODHD.
SOPH financial position
At the end of fiscal 2025 (December 31, 2025), SOPHiA GENETICS had total assets of $163.5 million (up 5.2% from a year earlier), total liabilities of $116.3 million and shareholders' equity of $47.1 million. It held $70.3 million in cash and short-term investments against $63.0 million of debt, a net cash position of $7.3 million. Its current ratio was 1.96. In the latest quarter (ended June 30, 2026) total assets were $198.4 million and equity $83.1 million.
Related: SOPH income statement, SOPH cash flow statement, SOPH key metrics. See the SOPH stock overview for the latest quote and news.
SOPH balance sheet FAQ
What are SOPHiA GENETICS's total assets?
SOPHiA GENETICS reported total assets of $163.5 million at the end of fiscal 2025 (December 31, 2025), compared with $155.3 million a year earlier.
How much debt does SOPHiA GENETICS have?
SOPHiA GENETICS had $63.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 1.34.
How much cash does SOPHiA GENETICS have?
SOPHiA GENETICS held $70.3 million in cash and short-term investments at the end of fiscal 2025; with $63.0 million of debt that is net cash of $7.3 million.
What is SOPHiA GENETICS's book value?
SOPHiA GENETICS's shareholders' equity (book value) was $47.1 million at the end of fiscal 2025, or $0.70 per share.
What is SOPHiA GENETICS's current ratio?
SOPHiA GENETICS had current assets of $99.1 million and current liabilities of $50.5 million, a current ratio of 1.96 (it can cover its short-term obligations).
How much goodwill does SOPHiA GENETICS have?
SOPHiA GENETICS carried $35.9 million of goodwill and intangible assets, 22.0% of total assets, at the end of fiscal 2025.